Lenka Borska

Lenka Borska

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Acta Medica (Hradec Kralove, Czech Republic)
Verified
Journal Article
Open access
PDF file
KKKateřIna Kondělková
KateřIna Kondělková
DVDoris Vokurková
Doris Vokurková
JKJana Krejsek
Jana Krejsek
LBLenka Borska
Lenka Borska
ZFZdeněk Fiala
Zdeněk Fiala
CACtirad Andrýs
Ctirad Andrýs
Regulatory T cells (Tregs) are a specialized subpopulation of T cells that act to suppress immune response, thereby maintaining homeostasis and self-tolerance. It has been shown that Tregs are able to inhibit T cell proliferation and cytokine production and play a critical role in preventing autoimmunity. Different subsets with various functions of Treg cells exist. Tregs can be usually identified by flow cytometry. The most specific marker for these cells is FoxP3, which is localized intracellulary. Selected surface markers such as CD25 high (high molecular density) and CD127 low (low molecular density) could serve as surrogate markers to detect Tregs in a routine clinical practice. Dysregulation in Treg cell frequency or functions may lead to the development of autoimmune disease. Therapeutical Treg modulation is considered to be a promising therapeutical approach to treat some selected disorders, such as allergies, and to prevent allograft rejection.

5 August 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
DHDrahomira Holmannova
Drahomira Holmannova
PBPavel Borsky
Pavel Borsky
TŠTereza Švadláková
Tereza Švadláková
LBLenka Borska
Lenka Borska
ZFZdenek Fiala
Zdenek Fiala
This review summarizes the current knowledge on current and future applications of carbon nanoparticles in medicine. The carbon nanoparticle family has a large number of representatives with unique physicochemical properties that make them good candidates for use in clinical medicine. The best-known (and most researched) carbon nanoparticles include graphene, graphene oxide, and carbon nanotubes. The main direction of use involves medical diagnostics, which includes bioimaging and the detection of chemicals or metabolites present in the body. Since the question of nanoparticle toxicity has not been fully answered, the use of nanoparticles in the fields of therapeutics (drug delivery), regenerative medicine (cell scaffolding, tissue engineering), and vaccine production is still under research and many in vivo studies are ongoing. These preclinical studies suggest that carbon nanoparticles have great potential for diagnosis and treatment; the results show that the nanoparticles used do not have significant toxic effects; however, great caution is needed before nanoparticles are introduced into routine clinical practice.

17 May 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
DHDrahomira Holmannova
Drahomira Holmannova
PBPavel Borsky
Pavel Borsky
TŠTereza Švadláková
Tereza Švadláková
LBLenka Borska
Lenka Borska
ZFZdenek Fiala
Zdenek Fiala
The presented review aims to summarize the knowledge regarding the reproductive and developmental toxicity of different types of carbon nanoparticles, such as graphene, graphene oxide, multi- and single-walled nanotubes, fullerenes, and nanodiamonds. Carbon nanoparticles have unique chemical and physical properties that make them an excellent material that can be applied in many fields of human activity, including industry, food processing, the pharmaceutical industry, or medicine. Although it has a high degree of biocompatibility, possible toxic effects on different tissue types must also be taken into account. Carbon nanoparticles are known to be toxic to the respiratory, cardiovascular, nervous, digestive system, etc., and, according to current studies, they also have a negative effect on reproduction and offspring development.

13 October 2017 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
MBMartin Beranek
Martin Beranek
ZFZdenek Fiala
Zdenek Fiala
JKJan Kremlacek
Jan Kremlacek
CACtirad Andrys
Ctirad Andrys
JKJan Krejsek
Jan Krejsek
LBLenka Borska
Lenka Borska

21 December 2016 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
SVSimona Vachatova
Simona Vachatova
CACtirad Andrys
Ctirad Andrys
JKJan Krejsek
Jan Krejsek
MSMiloslav Salavec
Miloslav Salavec
KEKarel Ettler
Karel Ettler
LBLenka Borska
Lenka Borska
The presented article studies the role of selected inflammatory and anti-inflammatory serum markers of psoriatic patients in the pathogenesis of metabolic syndrome (MS) and psoriasis. The study is based on the comparison between the group of psoriatic patients (74) and the control group (65). We found significantly higher BMI (p<0.05) and diastolic blood pressure (p<0.05) in the psoriatic patients. The values of waist circumference and BMI were significantly higher (p<0.05) in the male patients compared to the men in the control group. The analysis revealed significantly higher CRP (p<0.001), Lp-PLA2 (p<0.001), leptin (p<0.01), and resistin (p<0.01) levels in the psoriatic patients. Significantly higher levels of CRP (p<0.01), Lp-PLA2 (p<0.001), leptin (p<0.01), and resistin (p<0.05) were found in the patients with MS compared to the controls with MS. The level of adiponectin was significantly lower (p<0.01) in the patients with MS. Finally, we found significantly higher level of Lp-PLA2 (p<0.001) in the group of patients without MS compared to the controls without MS. In conclusion, observed inflammatory and anti-inflammatory markers (CRP, adiponectin, leptin, resistin, and Lp-PLA2) are involved in both pathogenesis of MS and pathogenesis of psoriasis. The level of Lp-PLA2 indicates the presence of subclinical atherosclerosis (cardiovascular risk) in psoriatic patients.

Verified
Journal Article
Open access
PDF file
LBLenka Borska
Lenka Borska
JKJan Kremlacek
Jan Kremlacek
CACtirad Andrys
Ctirad Andrys
JKJan Krejsek
Jan Krejsek
KHKvetoslava Hamakova
Kvetoslava Hamakova
ZFZdenek Fiala
Zdenek Fiala
In the pathogenesis of psoriasis, systemic inflammation and oxidative stress play mutual roles interrelated with metabolic syndrome (MetS). This study aims to map the selected markers of inflammation (C-reactive protein (CRP)), oxidative damage to nucleic acids (DNA/RNA damage; 8-hydroxy-2′-deoxyguanosine, 8-hydroxyguanosine, and 8-hydroxyguanine), and the parameters of MetS (waist circumference, fasting glucose, triglycerides, high-density lipoprotein (HDL) cholesterol, diastolic and systolic blood pressure) in a group of 37 patients with psoriasis (62% of MetS) and in 43 healthy controls (42% of MetS). Levels of CRP, DNA/RNA damage, fasting glucose, and triglycerides were significantly elevated in patients. MetS in conjunction with psoriasis was associated with high levels of CRP, significantly higher than in control subjects without MetS. Patients with MetS exhibited further DNA/RNA damage, which was significantly higher in comparison with the control group. Our study supports the independent role of psoriasis and MetS in the increase of CRP and DNA/RNA damage. The psoriasis contributes to an increase in the levels of both effects more significantly than MetS. The psoriasis also diminished the relationship between CRP and oxidative damage to nucleic acids existent in controls.